Literature DB >> 33584474

The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars.

Davide Mazzoni1, Claudia Vener1, Ketti Mazzocco1,2, Dario Monzani1,2, Gabriella Pravettoni1,2.   

Abstract

Entities:  

Keywords:  adherence; nocebo effect; oncology; rheumatology; shared decision-making

Year:  2021        PMID： 33584474      PMCID： PMC7873288          DOI： 10.3389/fpsyg.2021.605643

Source DB:  PubMed          Journal:  Front Psychol        ISSN： 1664-1078


× No keyword cloud information.
  16 in total

Review 1.  An overview on cognitive aspects implicated in medical decisions.

Authors:  Alessandra Gorini; Gabriella Pravettoni
Journal:  Eur J Intern Med       Date:  2011-07-07       Impact factor: 4.487

2.  Interchangeability of Biosimilars: A European Perspective.

Authors:  Pekka Kurki; Leon van Aerts; Elena Wolff-Holz; Thijs Giezen; Venke Skibeli; Martina Weise
Journal:  BioDrugs       Date:  2017-04       Impact factor: 5.807

3.  Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.

Authors:  Joan O'Callaghan; Margaret Bermingham; Maurice Leonard; Frank Hallinan; J Michael Morris; Una Moore; Brendan T Griffin
Journal:  Regul Toxicol Pharmacol       Date:  2017-06-27       Impact factor: 3.271

4.  A survey among hospital specialists and pharmacists about biosimilars.

Authors:  Luca Pasina; Gianluigi Casadei; Alessandro Nobili
Journal:  Eur J Intern Med       Date:  2016-07-25       Impact factor: 4.487

5.  One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology.

Authors:  Wieland D Müskens; Sanne A A Rongen-van Dartel; Steven Teerenstra; Eddy M M Adang; Piet L C M van Riel
Journal:  Rheumatol Adv Pract       Date:  2020-08-06

Review 6.  Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect.

Authors:  Mourad F Rezk; Burkhard Pieper
Journal:  Rheumatol Ther       Date:  2017-10-14

7.  Value as the key concept in the health care system: how it has influenced medical practice and clinical decision-making processes.

Authors:  Chiara Marzorati; Gabriella Pravettoni
Journal:  J Multidiscip Healthc       Date:  2017-03-21

8.  Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent.

Authors:  Lars Erik Kristensen; Rieke Alten; Luis Puig; Sandra Philipp; Tore K Kvien; Maria Antonia Mangues; Frank van den Hoogen; Karel Pavelka; Arnold G Vulto
Journal:  BioDrugs       Date:  2018-10       Impact factor: 5.807

9.  The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies.

Authors:  Johlee S Odinet; Chelsea E Day; Jennifer L Cruz; Gregory A Heindel
Journal:  J Manag Care Spec Pharm       Date:  2018-10

Review 10.  Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies.

Authors:  Alessandro Armuzzi; Luisa Avedano; Kay Greveson; Taegyun Kang
Journal:  J Crohns Colitis       Date:  2019-02-01       Impact factor: 9.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.